February 27, 2026 · Form 4 insider transaction
THOMAS FRANK E bought 5,000 shares of Larimar Therapeutics, Inc. at $5.00 per share, a transaction worth $25.0K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 3 days after the transaction.
Represents shares of common stock purchased in the underwritten offering of Larimar Therapeutics, Inc. at the offering price, which closed on February 27, 2026.